PubRank

Gustavo Mostoslavsky

Author PubWeight™ 88.01‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007 9.67
2 Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 2006 8.48
3 Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell 2011 7.41
4 Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells 2009 5.69
5 Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat Genet 2009 4.28
6 A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature 2009 3.44
7 Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. Stem Cells 2010 3.24
8 Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Cell Stem Cell 2010 3.08
9 Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector. Stem Cells 2010 2.62
10 Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. Cell Stem Cell 2013 2.45
11 Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature 2012 2.32
12 Angiopoietin-1 requires p190 RhoGAP to protect against vascular leakage in vivo. J Biol Chem 2007 1.81
13 Induced pluripotent stem cells: a novel frontier in the study of human primary immunodeficiencies. J Allergy Clin Immunol 2010 1.65
14 Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 2004 1.46
15 XRCC4 suppresses medulloblastomas with recurrent translocations in p53-deficient mice. Proc Natl Acad Sci U S A 2006 1.38
16 Dual-promoter lentiviral system allows inducible expression of noxious proteins in macrophages. J Immunol Methods 2007 1.36
17 Exogenous control of mammalian gene expression via modulation of translational termination. Nat Med 2006 1.30
18 Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndrome. J Clin Invest 2008 1.29
19 PPARalpha deficiency in inflammatory cells suppresses tumor growth. PLoS One 2007 1.24
20 New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer. J Transl Med 2012 1.23
21 Enhanced reprogramming and cardiac differentiation of human keratinocytes derived from plucked hair follicles, using a single excisable lentivirus. Cell Reprogram 2010 1.23
22 Clonal genetic and hematopoietic heterogeneity among human-induced pluripotent stem cell lines. Blood 2013 1.20
23 Application of induced pluripotent stem (iPS) cells in periodontal tissue regeneration. J Cell Physiol 2011 1.12
24 Generation of human induced pluripotent stem cells from peripheral blood using the STEMCCA lentiviral vector. J Vis Exp 2012 1.11
25 Critical-size calvarial bone defects healing in a mouse model with silk scaffolds and SATB2-modified iPSCs. Biomaterials 2011 1.07
26 The aryl hydrocarbon receptor directs hematopoietic progenitor cell expansion and differentiation. Blood 2013 1.06
27 An ES-like pluripotent state in FGF-dependent murine iPS cells. PLoS One 2010 1.05
28 FSP27 and PLIN1 interaction promotes the formation of large lipid droplets in human adipocytes. Biochem Biophys Res Commun 2013 1.04
29 Critical role for hematopoietic cell kinase (Hck)-mediated phosphorylation of Gab1 and Gab2 docking proteins in interleukin 6-induced proliferation and survival of multiple myeloma cells. J Biol Chem 2004 1.04
30 Mouse ES and iPS cells can form similar definitive endoderm despite differences in imprinted genes. J Clin Invest 2011 1.01
31 Residual expression of reprogramming factors affects the transcriptional program and epigenetic signatures of induced pluripotent stem cells. PLoS One 2012 0.98
32 Experimental approaches for the generation of induced pluripotent stem cells. Stem Cell Res Ther 2010 0.97
33 Cell reprogramming requires silencing of a core subset of polycomb targets. PLoS Genet 2013 0.95
34 Shb deficient mice display an augmented TH2 response in peripheral CD4+ T cells. BMC Immunol 2011 0.94
35 Treatment with a laminin-derived peptide suppresses lupus nephritis. J Immunol 2005 0.94
36 Benefits of utilizing gene-modified iPSCs for clinical applications. Cell Stem Cell 2010 0.92
37 BCAR3/AND-34 can signal independent of complex formation with CAS family members or the presence of p130Cas. Cell Signal 2011 0.91
38 The evolving field of induced pluripotency: recent progress and future challenges. J Cell Physiol 2013 0.90
39 Clonal allelic predetermination of immunoglobulin-κ rearrangement. Nature 2012 0.89
40 Induced pluripotent stem cell modeling of multisystemic, hereditary transthyretin amyloidosis. Stem Cell Reports 2013 0.89
41 The efficiency of B cell receptor (BCR) editing is dependent on BCR light chain rearrangement status. Eur J Immunol 2002 0.88
42 Consequences of Shb and c-Abl interactions for cell death in response to various stress stimuli. Exp Cell Res 2006 0.82
43 Trisomy 21 mid-trimester amniotic fluid induced pluripotent stem cells maintain genetic signatures during reprogramming: implications for disease modeling and cryobanking. Cell Reprogram 2014 0.78
44 RNA-Seq analysis of enteroendocrine cells reveals a role for FABP5 in the control of GIP secretion. Mol Endocrinol 2014 0.77
45 Risks Associated With Lentiviral Vector Exposures and Prevention Strategies. J Occup Environ Med 2016 0.75
46 Efficient transduction of hematopoietic stem cells and its potential for gene correction of hematopoietic diseases. Methods Mol Biol 2014 0.75
47 Lack of Immune Response to Differentiated Cells Derived from Syngeneic Induced Pluripotent Stem Cells. Cell Stem Cell 2017 0.75